Literature DB >> 21288692

Resequencing and follow-up of neurexin 1 (NRXN1) in schizophrenia patients.

Thomas W Mühleisen1, F Buket Basmanav, Andreas J Forstner, Manuel Mattheisen, Lutz Priebe, Stefan Herms, Rene Breuer, Susanne Moebus, Igor Nenadic, Heinrich Sauer, Rainald Mössner, Wolfgang Maier, Dan Rujescu, Michael Ludwig, Marcella Rietschel, Markus M Nöthen, Sven Cichon.   

Abstract

Large rare deletions in NRXN1 increase the risk for schizophrenia. The aim of the present study was to determine whether small rare sequence changes in exons and splice sites contribute to the development of schizophrenia in a high-penetrance manner. Complete coding regions and splice sites were resequenced in 94 patients and 94 controls. Among the 16 rare sequence variants, two missense substitutions (E201G and I1068V) were observed in single patients but not in controls. Investigation of DNA samples from family members and in silico analysis of possible effects on protein function produced no evidence of high-penetrance genetic effects. Follow-up genotyping of the most promising findings (E201G and I1068V) in an independent sample of >1400 patients and >1100 controls revealed no overrepresentation in patients compared to controls (E201G: 0/1 and I1068V: 0/0). Since I1068V was observed in a single patient, it is impossible to exclude the possibility that I1068V makes a minor contribution to schizophrenia susceptibility. Overall, however, the results do not suggest the existence of rare, highly penetrant NRXN1 mutations in patients with schizophrenia.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21288692     DOI: 10.1016/j.schres.2011.01.001

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  5 in total

1.  Identification of candidate single-nucleotide polymorphisms in NRXN1 related to antipsychotic treatment response in patients with schizophrenia.

Authors:  Aaron Jenkins; José A Apud; Fengyu Zhang; Heather Decot; Daniel R Weinberger; Amanda J Law
Journal:  Neuropsychopharmacology       Date:  2014-03-14       Impact factor: 7.853

2.  Sparse reduced-rank regression detects genetic associations with voxel-wise longitudinal phenotypes in Alzheimer's disease.

Authors:  Maria Vounou; Eva Janousova; Robin Wolz; Jason L Stein; Paul M Thompson; Daniel Rueckert; Giovanni Montana
Journal:  Neuroimage       Date:  2011-12-22       Impact factor: 6.556

3.  Molecular analysis of a deletion hotspot in the NRXN1 region reveals the involvement of short inverted repeats in deletion CNVs.

Authors:  Xiaoli Chen; Yiping Shen; Feng Zhang; Colby Chiang; Vamsee Pillalamarri; Ian Blumenthal; Michael Talkowski; Bai-Lin Wu; James F Gusella
Journal:  Am J Hum Genet       Date:  2013-03-07       Impact factor: 11.025

4.  Identification of gene ontologies linked to prefrontal-hippocampal functional coupling in the human brain.

Authors:  Luanna Dixson; Henrik Walter; Michael Schneider; Susanne Erk; Axel Schäfer; Leila Haddad; Oliver Grimm; Manuel Mattheisen; Markus M Nöthen; Sven Cichon; Stephanie H Witt; Marcella Rietschel; Sebastian Mohnke; Nina Seiferth; Andreas Heinz; Heike Tost; Andreas Meyer-Lindenberg
Journal:  Proc Natl Acad Sci U S A       Date:  2014-06-16       Impact factor: 11.205

5.  Deletion of glutamate delta-1 receptor in mouse leads to aberrant emotional and social behaviors.

Authors:  Roopali Yadav; Subhash C Gupta; Brandon G Hillman; Jay M Bhatt; Dustin J Stairs; Shashank M Dravid
Journal:  PLoS One       Date:  2012-03-07       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.